Research Article
Impact of Prediabetes and Type-2 Diabetes on Outcomes in Patients with COVID-19
Table 2
Binomial regression analysis for mortality.
| | | Odds ratio | -value |
| | Age | 1.03 (1.02–1.05) | 0.001 | | Control | 0.00 (0.00–0.00) | 0.83 | | Prediabetes | 0.84 (0.47–1.49) | 0.55 | | Diabetes mellitus | 0.94 (0.57–1.55) | 0.82 | | BMI | 1.02 (1.00–1.04) | 0.12 | | HIV/AIDS | 0.36 (0.20–0.65) | 0.001 | | Hypertension | 0.91 (0.60–1.37) | 0.64 | | CAD | 0.69 (0.43–1.11) | 0.13 | | Absolute neutrophil count | 1.02 (0.97–1.06) | 0.45 | | CRP | 1.00 (1.00–1.01) | 0.001 | | Hydroxychloroquine | 0.48 (0.31–0.76) | 0.002 | | Tamiflu | 0.77 (0.41–1.42) | 0.40 |
|
|